DIN 02555972 — LAZCLUZE 240 MG
LAZCLUZE is a tablet of Lazertinib marketed by JANSSEN INC. The full Lazertinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02555972
- Brand name
- LAZCLUZE
- Active ingredient
- Lazertinib
- Strength
- 240 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- JANSSEN INC
- Health Canada status
- MARKETED
- Drug class
- Third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Lazertinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02555964 | LAZCLUZE | 80 MG | TABLET | JANSSEN INC | MARKETED |